Arthritogenic action of gliostatin in rheumatoid arthritis and its molecular mechanism.
Arthritogenic action of gliostatin in rheumatoid arthritis and its molecular mechanism.
批准号:
13671529
负责人:
OTSUKA Takanobu
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
在类风湿关节炎(RA)的病理组织学中,滑膜细胞的新生血管、增殖以及单核细胞的涌入和激活是滑膜关节的特征事件。本研究的目的是探讨胶质抑制素/血小板衍生内皮细胞生长因子(GLS/PD-ECGF)如何参与RA软骨退化的分子机制,以及血清GLS的测定是否可用于评估RA手术(关节成形术或滑膜切除术)后症状的改善。兔膝关节内注射rHuGLS可导致弥漫性滑膜炎、软骨细胞破坏和类风湿性关节炎的血管疙瘩形成。培养软骨肉瘤细胞系(OUMS-27),用白细胞介素1β(IL-1β)干预。IL-1β可诱导MMP1、MMP13和GLS的表达。关节置换术后RA患者血清GLS水平下降,提示GLS是MMPs介导的RA关节广泛破坏的可能致病因素,人类GLS可通过胸苷磷酸化酶以外的其他机制引起类风湿性滑膜炎,血清GLS水平可作为评价滑膜炎和手术治疗系统疗效的有用指标。
英文摘要
Neovascularization, proliferation of synovial cells, and mononuclear cell influx and activation are characteristic events observed in synovial joints in the pathohistology of rheumatoid arthritis (RA). The purposes of this study are to examine how gliostatin/platelet derived-endothelial cell growth factor (GLS/PD-ECGF) is involved in the molecular mechanism of cartilage degradation and whether measurement of serum GLS can be used to evaluate symptomatic improvements after surgery (arthroplasty or synovectomy) in RA.Intraarticular injection of rHuGLS in rabbit knee joints resulted in development of diffuse synovitis, chondrocytes destruction, and pannus formation resembling rheumatoid arthritis. A chondrosarcoma cell line (OUMS-27) was cultured and treated with interleukin-lβ (IL-1β). IL-1β induced the expression of matrix metalloproteinase (MMP)-1, MMP-13, and GLS. Patients with RA undergoing arthroplasty demonstrated a decrease in serum GLS levels after operations.These findings suggest that GLS is a plausible pathogenic factor causing the extensive joint destruction in RA mediated via MMPs and that human GLS can cause RA-like synovitis via a mechanism other than its thymidine phosphorylase activity and that the serum GLS level is a useful indicator for evaluation of synovitis and the systemic efficacy of surgical treatment.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
松井宣夫, 永谷祐子: "慢性関節リウマチ-21世紀に向けての診断と治療-"中部リウマチ(J Chubu Rheum Assoc). 32. 10-16 (2001)
Nobuo Matsui,Yuko Nagatani:“慢性类风湿性关节炎 - 21 世纪的诊断和治疗” Chubu Rheum Assoc。 32. 10-16 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ieda Y, Waguri-Nagaya Y, Otsuka T, et al.: "IL-1β induced expression of matrix metalloproteinases and gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) in a chondrosarcoma cell line (OUMS-27)"Rheumatol Int.. 21. 45-52 (2001)
Ieda Y、Waguri-Nagaya Y、Otsuka T 等人:“IL-1β 诱导软骨肉瘤细胞系 (OUMS-27) 中基质金属蛋白酶和胶质抑素/血小板衍生内皮细胞生长因子 (GLS/PD-ECGF) 的表达)“风湿病国际.. 21. 45-52 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ieda Y, Waguri-Nagaya Y, Otsuka T, et al.: "IL-1B induced expression of MMP and gliostatin/PbECGF in chondrosareoua cell line (OUMS-27)"Rheumafology International. 21. 45-52 (2001)
Ieda Y、Waguri-Nagaya Y、Otsuka T 等人:“IL-1B 在软骨细胞系 (OUMS-27) 中诱导 MMP 和胶质抑素/PbECGF 的表达”Rheumafology International。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsui N, Waguri-Nagaya Y, Taneda Y: "Diagnosis and therapy of rheumatoid arthritis in the future"Mod Rheumatol. 11. 286-291 (2001)
Matsui N、Waguri-Nagaya Y、Taneda Y:“未来类风湿性关节炎的诊断和治疗”Mod Rheumatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Muro H, Waguri-Nagaya Y, Otsuka T, et al.: "Serum gliostatin levels in patients with rheumatoid factor-negative and -positive rheumatoid arthritis and changes of these levels after surgical treatment"Clin Rheumatol. 20. 331-336 (2001)
Muro H、Waguri-Nagaya Y、Otsuka T 等人:“类风湿因子阴性和阳性类风湿性关节炎患者的血清胶质抑素水平以及手术治疗后这些水平的变化”Clin Rheumatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Aquaporins expression in fibroblast like synoviocytes from OA and RA patients
-
批准号:24592272
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:OTSUKA Takanobu
-
依托单位:
Aquaporin expression in the synovial tissues of patients with rheumatoid arthritis and osteoarthritis
-
批准号:19591760
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:OTSUKA Takanobu
-
依托单位:
Gliostatin as a clinical marker of rheumatoid arthritis and its regulation
-
批准号:07671612
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1995
-
负责人:OTSUKA Takanobu
-
依托单位:
海外基金